These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27027402)

  • 1. Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR-S1PR2-dependent mechanism.
    Xu W; Lu C; Zhang F; Shao J; Zheng S
    IUBMB Life; 2016 May; 68(5):376-87. PubMed ID: 27027402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
    Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
    FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroartemisinin prevents liver fibrosis in bile duct ligated rats by inducing hepatic stellate cell apoptosis through modulating the PI3K/Akt pathway.
    Chen Q; Chen L; Wu X; Zhang F; Jin H; Lu C; Shao J; Kong D; Wu L; Zheng S
    IUBMB Life; 2016 Mar; 68(3):220-31. PubMed ID: 26865509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous S1P via S1P receptor 2 induces CTGF expression through Src-RhoA-ROCK-YAP pathway in hepatic stellate cells.
    Park S; Kim J; Yang S; Kang SH; Kang W; Paik YH
    Mol Biol Rep; 2024 Sep; 51(1):950. PubMed ID: 39222158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions.
    Yang J; Tang X; Liang Z; Chen M; Sun L
    Clin Mol Hepatol; 2023 Apr; 29(2):465-481. PubMed ID: 36800698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probucol ameliorates hepatic stellate cell activation and autophagy is associated with farnesoid X receptor.
    Yang R; Hu Z; Zhang P; Wu S; Song Z; Shen X; Wei Z
    J Pharmacol Sci; 2019 Feb; 139(2):120-128. PubMed ID: 30638990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of endothelin-1-mediated contraction of hepatic stellate cells by FXR ligand.
    Li J; Kuruba R; Wilson A; Gao X; Zhang Y; Li S
    PLoS One; 2010 Nov; 5(11):e13955. PubMed ID: 21085652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis.
    Zhang Z; Yao Z; Zhao S; Shao J; Chen A; Zhang F; Zheng S
    Cell Death Dis; 2017 Jun; 8(6):e2886. PubMed ID: 28617435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner.
    Xu W; Lu C; Yao L; Zhang F; Shao J; Zheng S
    Toxicol Appl Pharmacol; 2017 Jan; 315():23-34. PubMed ID: 27939985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydroartemisinin alleviates hepatic fibrosis through inducing ferroptosis in hepatic stellate cells.
    Zhang Z; Wang X; Wang Z; Zhang Z; Cao Y; Wei Z; Shao J; Chen A; Zhang F; Zheng S
    Biofactors; 2021 Sep; 47(5):801-818. PubMed ID: 34129254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m
    Shen M; Guo M; Li Y; Wang Y; Qiu Y; Shao J; Zhang F; Xu X; Yin G; Wang S; Chen A; Zhang Z; Zheng S
    Free Radic Biol Med; 2022 Mar; 182():246-259. PubMed ID: 35248719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand.
    Carino A; Biagioli M; Marchianò S; Scarpelli P; Zampella A; Limongelli V; Fiorucci S
    Pharmacol Res; 2018 May; 131():17-31. PubMed ID: 29530598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
    Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
    World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells.
    Wang F; Jia Y; Li M; Wang L; Shao J; Guo Q; Tan S; Ding H; Chen A; Zhang F; Zheng S
    Cell Commun Signal; 2019 Feb; 17(1):11. PubMed ID: 30744642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroartemisinin regulates lipid droplet metabolism in hepatic stellate cells by inhibiting lncRNA-H19-induced AMPK signal.
    Xia S; Wang Z; Chen L; Zhou Y; Li Y; Wang S; Chen A; Xu X; Shao J; Zhang Z; Tan S; Zhang F; Zheng S
    Biochem Pharmacol; 2021 Oct; 192():114730. PubMed ID: 34400125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone induction of hepatic stellate cell contraction through activation of RhoA/ROCK-2 signaling pathway.
    Ji H; Meng Y; Zhang X; Luo W; Wu P; Xiao B; Zhang Z; Li X
    Regul Pept; 2011 Aug; 169(1-3):13-20. PubMed ID: 21545816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL12 induces hepatic stellate cell contraction through a calcium-independent pathway.
    Saiman Y; Agarwal R; Hickman DA; Fausther M; El-Shamy A; Dranoff JA; Friedman SL; Bansal MB
    Am J Physiol Gastrointest Liver Physiol; 2013 Sep; 305(5):G375-82. PubMed ID: 23812037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
    Shi Z; Ren M; Rockey DC
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G504-G517. PubMed ID: 31928221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blockade of lipophagy pathway is necessary for docosahexaenoic acid to regulate lipid droplet turnover in hepatic stellate cells.
    Qiu S; Xu H; Lin Z; Liu F; Tan F
    Biomed Pharmacother; 2019 Jan; 109():1841-1850. PubMed ID: 30551439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
    Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
    Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.